Paper306574
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
Woosley RL and 5 others. N Engl J Med, 1978. Cited by 221 papers, by iCite.
Cite this record
ConductScience Library. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Papers, record 306574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/306574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Antinuclear | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Procainamide | Major topic |
| Acetylation | |
| Adult | |
| Aged | |
| Biotransformation | |
| History, 18th Century | |
| Humans | |
| Middle Aged | |
| Phenotype | |
| Retrospective Studies | |
| Time Factors |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649250 | Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42649250 | PubMed |
| 38436771 | Mendelian randomization study on causal association of FAM210B with drug-induced lupus. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38436771 | PubMed |
| 36714114 | Reliability and reproducibility of antinuclear antibody testing in pediatric rheumatology practice. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36714114 | PubMed |
| 35035679 | Illustrative and historic cases of phenoconversion. | Am J Transl Res | 2021 | https://conductscience.org/library/papers/35035679 | PubMed |
| 34662650 | Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy. | Kidney Int | 2021 | https://conductscience.org/library/papers/34662650 | PubMed |
| 33094670 | Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. | Expert Opin Drug Metab Toxicol | 2021 | https://conductscience.org/library/papers/33094670 | PubMed |
| 31497427 | Clinical Characteristics of Hydralazine-induced Lupus. | Cureus | 2019 | https://conductscience.org/library/papers/31497427 | PubMed |
| 30135300 | Precision DNA demethylation ameliorates disease in lupus-prone mice. | JCI Insight | 2018 | https://conductscience.org/library/papers/30135300 | PubMed |
| 29870500 | Drug-induced lupus erythematosus: an update on drugs and mechanisms. | Curr Opin Rheumatol | 2018 | https://conductscience.org/library/papers/29870500 | PubMed |
| 28879482 | Pristane-induced lupus: considerations on this experimental model. | Clin Rheumatol | 2017 | https://conductscience.org/library/papers/28879482 | PubMed |
| 27652979 | Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities. | Nat Commun | 2016 | https://conductscience.org/library/papers/27652979 | PubMed |
| 26092827 | Drug-induced glomerular disease: immune-mediated injury. | Clin J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/26092827 | PubMed |
| 24467436 | Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24467436 | PubMed |
| 22387617 | Metabolomics reveals the metabolic map of procainamide in humans and mice. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/22387617 | PubMed |
| 22300536 | Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. | Arthritis Res Ther | 2012 | https://conductscience.org/library/papers/22300536 | PubMed |
| 20972370 | Deleterious effects of reactive metabolites. | Oxid Med Cell Longev | 2010 | https://conductscience.org/library/papers/20972370 | PubMed |
| 20836007 | Pharmacogenomics: a systems approach. | Wiley Interdiscip Rev Syst Biol Med | 2010 | https://conductscience.org/library/papers/20836007 | PubMed |
| 20544243 | Acrylamine-induced autoimmune phenomena. | Clin Rheumatol | 2010 | https://conductscience.org/library/papers/20544243 | PubMed |
| 18748470 | The relationship between genetics and environment in the pathogenesis of rheumatic diseases. | West J Med | 1979 | https://conductscience.org/library/papers/18748470 | PubMed |
| 18679519 | Drug therapy considerations in arrhythmias in children. | Indian Pacing Electrophysiol J | 2008 | https://conductscience.org/library/papers/18679519 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/306574
GET https://conductscience.org/api/papers/v1/306574/cited_by?page=2